The use of cytapheresis in the treatment of infectious diseases

Andrew P. Norgan, Justin E. Juskewitch, Bobbi S. Pritt, Jeffrey L. Winters

Research output: Contribution to journalArticle

Abstract

Cytapheresis (removal of cellular blood components) has been employed for treatment of infectious diseases since the 1960s. Techniques have included thrombocytapheresis (buffy coat apheresis) for loiasis, erythrocytapheresis for malaria and babesiosis, and leukocytapheresis for pertussis-associated lymphocytosis. Published data on these applications is largely limited to case level data and small observational studies; as such, recommendations for or against the use of cytapheresis in the treatment of infections have been extrapolated from these limited (and at times flawed) data sets. Consequently, utilization of cytapheresis in many instances is not uniform between institutions, and typically occurs at the discretion of treating medical teams. This review revisits the existing literature on the use of cytapheresis in the treatment of four infections (loasis, malaria, babesiosis, and pertussis) and examines the rationale underlying current treatment recommendations concerning its use.

Original languageEnglish (US)
JournalJournal of Clinical Apheresis
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Cytapheresis
Communicable Diseases
Babesiosis
Blood Component Removal
Whooping Cough
Malaria
Loiasis
Plateletpheresis
Leukapheresis
Lymphocytosis
Therapeutics
Infection
Observational Studies

Keywords

  • Apheresis
  • Cytapheresis
  • Infectious disease
  • Malaria
  • Microfilaria

ASJC Scopus subject areas

  • Hematology

Cite this

Norgan, A. P., Juskewitch, J. E., Pritt, B. S., & Winters, J. L. (Accepted/In press). The use of cytapheresis in the treatment of infectious diseases. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.21620

The use of cytapheresis in the treatment of infectious diseases. / Norgan, Andrew P.; Juskewitch, Justin E.; Pritt, Bobbi S.; Winters, Jeffrey L.

In: Journal of Clinical Apheresis, 01.01.2018.

Research output: Contribution to journalArticle

Norgan, Andrew P. ; Juskewitch, Justin E. ; Pritt, Bobbi S. ; Winters, Jeffrey L. / The use of cytapheresis in the treatment of infectious diseases. In: Journal of Clinical Apheresis. 2018.
@article{9cc4c298ba2f44cd8ce7d7c254b0cae1,
title = "The use of cytapheresis in the treatment of infectious diseases",
abstract = "Cytapheresis (removal of cellular blood components) has been employed for treatment of infectious diseases since the 1960s. Techniques have included thrombocytapheresis (buffy coat apheresis) for loiasis, erythrocytapheresis for malaria and babesiosis, and leukocytapheresis for pertussis-associated lymphocytosis. Published data on these applications is largely limited to case level data and small observational studies; as such, recommendations for or against the use of cytapheresis in the treatment of infections have been extrapolated from these limited (and at times flawed) data sets. Consequently, utilization of cytapheresis in many instances is not uniform between institutions, and typically occurs at the discretion of treating medical teams. This review revisits the existing literature on the use of cytapheresis in the treatment of four infections (loasis, malaria, babesiosis, and pertussis) and examines the rationale underlying current treatment recommendations concerning its use.",
keywords = "Apheresis, Cytapheresis, Infectious disease, Malaria, Microfilaria",
author = "Norgan, {Andrew P.} and Juskewitch, {Justin E.} and Pritt, {Bobbi S.} and Winters, {Jeffrey L.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jca.21620",
language = "English (US)",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - The use of cytapheresis in the treatment of infectious diseases

AU - Norgan, Andrew P.

AU - Juskewitch, Justin E.

AU - Pritt, Bobbi S.

AU - Winters, Jeffrey L.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Cytapheresis (removal of cellular blood components) has been employed for treatment of infectious diseases since the 1960s. Techniques have included thrombocytapheresis (buffy coat apheresis) for loiasis, erythrocytapheresis for malaria and babesiosis, and leukocytapheresis for pertussis-associated lymphocytosis. Published data on these applications is largely limited to case level data and small observational studies; as such, recommendations for or against the use of cytapheresis in the treatment of infections have been extrapolated from these limited (and at times flawed) data sets. Consequently, utilization of cytapheresis in many instances is not uniform between institutions, and typically occurs at the discretion of treating medical teams. This review revisits the existing literature on the use of cytapheresis in the treatment of four infections (loasis, malaria, babesiosis, and pertussis) and examines the rationale underlying current treatment recommendations concerning its use.

AB - Cytapheresis (removal of cellular blood components) has been employed for treatment of infectious diseases since the 1960s. Techniques have included thrombocytapheresis (buffy coat apheresis) for loiasis, erythrocytapheresis for malaria and babesiosis, and leukocytapheresis for pertussis-associated lymphocytosis. Published data on these applications is largely limited to case level data and small observational studies; as such, recommendations for or against the use of cytapheresis in the treatment of infections have been extrapolated from these limited (and at times flawed) data sets. Consequently, utilization of cytapheresis in many instances is not uniform between institutions, and typically occurs at the discretion of treating medical teams. This review revisits the existing literature on the use of cytapheresis in the treatment of four infections (loasis, malaria, babesiosis, and pertussis) and examines the rationale underlying current treatment recommendations concerning its use.

KW - Apheresis

KW - Cytapheresis

KW - Infectious disease

KW - Malaria

KW - Microfilaria

UR - http://www.scopus.com/inward/record.url?scp=85042532538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042532538&partnerID=8YFLogxK

U2 - 10.1002/jca.21620

DO - 10.1002/jca.21620

M3 - Article

C2 - 29488237

AN - SCOPUS:85042532538

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

ER -